An interesting case of vitiligo development following autologous colon tumor vaccine therapy

P. Angelos, A. B. Benson, S. T. Rosen, R. B. Duda*

*Corresponding author for this work

Research output: Contribution to journalShort survey

Abstract

A patient with no previous history of vitiligo developed progressive vitiligo 2 years after receiving treatment with an immunocompetent vaccine for Stage D colorectal carcinoma. The patient's prolonged survival with metastases to the liver suggests the possibility of an immunologic response to the tumor vaccine associated with vitiligo. Although vitiligo has been reported in association with gastrointestinal carcinomas in the past, this is the first reported case following experimental autologous tumor vaccine therapy.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalVaccine Research
Volume4
Issue number1
StatePublished - Jan 1 1995

Fingerprint

Active Immunotherapy
Vitiligo
Cancer Vaccines
Colon
Colorectal Neoplasms
Vaccines
Neoplasm Metastasis
Carcinoma
Survival
Liver
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Microbiology (medical)

Cite this

Angelos, P. ; Benson, A. B. ; Rosen, S. T. ; Duda, R. B. / An interesting case of vitiligo development following autologous colon tumor vaccine therapy. In: Vaccine Research. 1995 ; Vol. 4, No. 1. pp. 47-52.
@article{7bf87661feda4508be116a432695bf7a,
title = "An interesting case of vitiligo development following autologous colon tumor vaccine therapy",
abstract = "A patient with no previous history of vitiligo developed progressive vitiligo 2 years after receiving treatment with an immunocompetent vaccine for Stage D colorectal carcinoma. The patient's prolonged survival with metastases to the liver suggests the possibility of an immunologic response to the tumor vaccine associated with vitiligo. Although vitiligo has been reported in association with gastrointestinal carcinomas in the past, this is the first reported case following experimental autologous tumor vaccine therapy.",
author = "P. Angelos and Benson, {A. B.} and Rosen, {S. T.} and Duda, {R. B.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "47--52",
journal = "Vaccine Research",
issn = "1056-7909",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

An interesting case of vitiligo development following autologous colon tumor vaccine therapy. / Angelos, P.; Benson, A. B.; Rosen, S. T.; Duda, R. B.

In: Vaccine Research, Vol. 4, No. 1, 01.01.1995, p. 47-52.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - An interesting case of vitiligo development following autologous colon tumor vaccine therapy

AU - Angelos, P.

AU - Benson, A. B.

AU - Rosen, S. T.

AU - Duda, R. B.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - A patient with no previous history of vitiligo developed progressive vitiligo 2 years after receiving treatment with an immunocompetent vaccine for Stage D colorectal carcinoma. The patient's prolonged survival with metastases to the liver suggests the possibility of an immunologic response to the tumor vaccine associated with vitiligo. Although vitiligo has been reported in association with gastrointestinal carcinomas in the past, this is the first reported case following experimental autologous tumor vaccine therapy.

AB - A patient with no previous history of vitiligo developed progressive vitiligo 2 years after receiving treatment with an immunocompetent vaccine for Stage D colorectal carcinoma. The patient's prolonged survival with metastases to the liver suggests the possibility of an immunologic response to the tumor vaccine associated with vitiligo. Although vitiligo has been reported in association with gastrointestinal carcinomas in the past, this is the first reported case following experimental autologous tumor vaccine therapy.

UR - http://www.scopus.com/inward/record.url?scp=0029119323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029119323&partnerID=8YFLogxK

M3 - Short survey

VL - 4

SP - 47

EP - 52

JO - Vaccine Research

JF - Vaccine Research

SN - 1056-7909

IS - 1

ER -